Technical Analysis for AMGN - Amgen Inc.

Grade Last Price % Change Price Change
grade A 192.07 -2.76% -5.46
AMGN closed down 2.76 percent on Friday, December 14, 2018, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical AMGN trend table...

Date Alert Name Type % Chg
Dec 14 Fell Below 20 DMA Bearish 0.00%
Dec 14 Fell Below 50 DMA Bearish 0.00%
Dec 14 MACD Bearish Centerline Cross Bearish 0.00%
Dec 14 180 Bearish Setup Bearish Swing Setup 0.00%
Dec 14 Cup with Handle Other 0.00%
Dec 13 20 DMA Support Bullish -2.76%
Dec 13 Crossed Above 50 DMA Bullish -2.76%
Dec 13 Cup with Handle Other -2.76%
Dec 13 Narrow Range Bar Range Contraction -2.76%
Dec 13 NR7 Range Contraction -2.76%

Older signals for AMGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases; Aranesp and EPOGEN erythropoiesis-stimulating agents that stimulate the production of red blood cells; and XGEVA/Prolia (denosumab) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas comprising oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc; Takeda Pharmaceutical Company Limited; and UCB, as well as a strategic alliance with Astellas Pharma Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Is AMGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 210.19
52 Week Low 163.31
Average Volume 2,926,528
200-Day Moving Average 189.077
50-Day Moving Average 195.9896
20-Day Moving Average 196.709
10-Day Moving Average 197.567
Average True Range 5.2414
ADX 13.11
+DI 20.2509
-DI 25.5708
Chandelier Exit (Long, 3 ATRs ) 193.2658
Chandelier Exit (Short, 3 ATRs ) 202.8442
Upper Bollinger Band 205.149
Lower Bollinger Band 188.269
Percent B (%b) 0.23
BandWidth 8.581204
MACD Line -0.0018
MACD Signal Line 0.4944
MACD Histogram -0.4962
Fundamentals Value
Market Cap 140.15 Billion
Num Shares 730 Million
EPS 10.98
Price-to-Earnings (P/E) Ratio 17.49
Price-to-Sales 5.59
Price-to-Book 4.07
PEG Ratio 3.29
Dividend 4.60
Dividend Yield 2.39%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 198.81
Resistance 3 (R3) 199.42 197.78 197.68
Resistance 2 (R2) 197.78 196.07 197.48 197.31
Resistance 1 (R1) 194.93 195.01 194.11 194.32 196.93
Pivot Point 193.29 193.29 192.89 192.99 193.29
Support 1 (S1) 190.44 191.58 189.62 189.83 187.21
Support 2 (S2) 188.80 190.52 188.50 186.83
Support 3 (S3) 185.95 188.80 186.46
Support 4 (S4) 185.34